---
title: "aya all"
slug: "yes-all"
date: "2024-01-21"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ªï¼š[[acute lymphoblastic leukemia]]

# aya all

1. Goekbuget N, StoltefuÃŸ A, Topp MS, et al. Dose Reduced Chemotherapy in Sequence with Blinatumomab for Newly Diagnosed Older Patients with B-Precursor Adult Lymphoblastic Leukemia (ALL): Results of the Ongoing GMALL Bold Trial. Blood. 2021;138(Supplement 1):3399-3399. doi:<https://doi.org/10.1182/blood-2021-146214>
2. Aldoss I. Revumenib Monotherapy in Patients with Relapsed/Refractory KMT2Ar Acute Leukemia: Topline Efficacy and Safety Results from the Pivotal Augment-101 Phase 2 Study. Confex.com. Published 2023. Accessed January 21, 2024. <https://ash.confex.com/ash/2023/webprogram/Paper192042.html>
3. [[revumenib.md|Revumenib]]
4. 



### Backlink

- [[revumenib]] 
- [[acute lymphoblastic leukemia]] 
